We are the only UK charity funding medical research specifically into cancer affecting teenagers and young adults, where it can frequently strike in dangerous and complex forms. We also funds measures to improve the quality of life for young cancer patients, both during and in the aftermath of their illnesses.
Never doubt the value of research: ongoing medical research is vitally important.
Research funded from the money we raise helps increase understanding of cancer in 13-24-year-olds, improves treatments, brings new and exciting breakthroughs and better methods of prevention and detection, and ultimately saves more young lives.
84% of teenagers and young adults have survived cancer for more than 5 years in England and Wales; that is four out of five young people. We want that to continue improving.
Read here about the ground-breaking research currently taking place at the University of Huddersfield.
A new form of treatment based on the molecule named CD40, which destroys cancerous tumours without harming healthy cell tissue – University of Huddersfield.
Two-year project, 'The Impact of Specialist Treatment Centres on Cancer Survival and 'Cure' Among Young People in England & Wales'. - London School of Hygiene and tropical Medicine.
One-year research project looking at 'The Influence of the Epstein Barr Virus on Chemotherapy Response in Hodkgin's Lymphoma'. - University of Birmingham
Four-year project, 'Long-term Cancer Survival: Models of Follow-up; Evidence and Impact of Late Effects. - Weston Park Hospital, Sheffield. The study received national and international acclaim and is now being used as a model for future studies. The findings from the project will ensure that teenagers and young adults who have received treatment for cancer will have access to support for the longer term, addressing physical and psychological issues that have arisen due to their cancer and/or their treatments.
One-year project, 'Characterisation of a Novel Stem Cell Population for Exploitation in Tumour Therapy.' (Leeds)
'Growth Factors in Tumours of the Ewing's Sarcoma Family'.
The Laura Crane Youth Cancer Trust supports measures to improve the quality of life for teenage cancer patients during their frequent and debilitating stays in hospitals. Teenagers are an age group onto themselves and require occupational and social activities to help keep up their motivation.
Cancer is the most common form of non-accidental death in teenagers and young adults in the UK.
There are many types of cancers that behave differently with young people, and more rare cases are discovered each year.
Every day in the UK (approximately) seven young people (aged between 13 and 24) are diagnosed with cancer.
84% of teenagers and young adults have survived cancer for more than 5 years in England and Wales; that is four out of five young people.
fund medical and social research into cancers that affect the 13-24-year-old age group
provide support mechanisms, such as technology, to remove feelings of isolation and improve time spent on hospital wards for young cancer patients.
provide grants to young cancer patients to invest in mechanisms that improve their quality of life during and after cancer and its treatments.
work with 43 hospitals across the UK, as well as collaboratively with other organisations to maximise reach and ensure that all young cancer patients receive the support they need to fight cancer.
each year we deliver thousands of gifts to young cancer patients across the UK at Christmas? In 2017 we delivered 1,281 to 43 hospitals.
we have granted 32 grants (as at the end of 2017) for young cancer patients in the Yorkshire area, to invest in something that would improve their quality of life during and after treatment.
we have provided 18 hospitals across the UK (as at the end of 2017) with laptop libraries to enable those in isolation communicate with the outside world.
Sign up for our newsletter to our latest news, event invitations, and more.
Get the newsletter